//

Media

Filter by Category

All Blog News Podcasts Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

February 20, 2018

2018 ISCTM Distinguished Poster Award Winner: “Global Regulatory Agencies Support Dopamine Transporter Neuroimaging in Clinical Trials Targeting Parkinson’s disease”

December 8, 2017

Characterizing Disease Progression for Parkinson’s Disease to implement efficient trial designs

December 8, 2017

Model-Informed Biomarker Qualification: Alzheimer and Parkinson Disease Imaging Biomarkers

November 15, 2017

Using Data to Reimagine Clinical Trials

Dopamine Transporter Neuroimaging as an Enrichment Biomarker in Early Parkinson’s Disease Clinical Trials: A Disease Progression Modeling Analysis

Conrado DJ, Nicholas T, Tsai K, Macha S, Sinha V, Stone J, Corrigan B, Bani M, Muglia P, Watson IA, Kern VD, Sheveleva E, Marek K,

The FDA is Listening: Integrating the Voice of the Patient in Drug Development for Parkinson’s and Huntington’s Diseases

The Critical Path for Parkinson’s Consortium: Understanding Motor Disease Progression Through Quantitative Medicine

Global Regulatory Agencies Support the Use of Dopamine Transporter Neuroimaging for Subject Selection in Clinical Trials Targeting Early Stage Parkinson’s Disease

Critical Path for Parkinson’s Consortium achieves regulatory support in Europe for use of imaging biomarker in Parkinson’s disease clinical trials

Oct 10, 2016 Critical Path for Parkinson’s Consortium achieves regulatory support in Europe for use of imaging

Critical Path for Parkinson’s: Regulatory Path to Enable Targeting the Right Patients in Clinical Trials of Early Stages of Parkinson’s Disease

Previous1011 Next